(Q34974091)

English

Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway?

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

1 reference

Europe PubMed Central

Activation of the protective Survivor Activating Factor Enhancement (SAFE) pathway against reperfusion injury: Does it go beyond the RISK pathway? (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

reperfusion injury

1 reference

based on heuristic

inferred from title

author name string

Sandrine Lecour

1

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

publication date

31 March 2009

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Journal of Molecular and Cellular Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

47

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

32-40

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Reperfusion injury and its pharmacologic modification

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Myocardial reperfusion injury.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Long-term benefit of postconditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Fighting the "fire" of myocardial reperfusion injury: how to define success?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Reperfusion injury in humans: a review of clinical trials on reperfusion injury inhibitory strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Multiple protective pathways against reperfusion injury: a SAFE path without Aktion?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Effect of cyclosporine on reperfusion injury in acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Stress-activated cytokines and the heart: from adaptation to maladaptation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

TNFalpha is required to confer protection in an in vivo model of classical ischaemic preconditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Bidirectional role of tumor necrosis factor-alpha in coronary microembolization: progressive contractile dysfunction versus delayed protection against infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Innate immunity and cardiac preconditioning: a putative intrinsic cardioprotective program

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Innate immunity and myocardial adaptation to ischemia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Pharmacological preconditioning with tumor necrosis factor-alpha activates signal transducer and activator of transcription-3 at reperfusion without involving classic prosurvival kinases (Akt and extracellular signal-regulated kinase).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Dual activation of STAT-3 and Akt is required during the trigger phase of ischaemic preconditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Cardioprotection: nitric oxide, protein kinases, and mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Ligand triggers of classical preconditioning and postconditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Ischemic postconditioning in pigs: no causal role for RISK activation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Sphingosine can pre- and post-condition heart and utilizes a different mechanism from sphingosine 1-phosphate

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Identification of a novel role for sphingolipid signaling in TNF alpha and ischemic preconditioning mediated cardioprotection

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Classic ischemic but not pharmacologic preconditioning is abrogated following genetic ablation of the TNFalpha gene

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Coronary microembolization: the role of TNF-alpha in contractile dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Elevated circulating levels of tumor necrosis factor in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

TNF alpha receptor expression in rat cardiac myocytes: TNF alpha inhibition of L-type Ca2+ current and Ca2+ transients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Expression and Functional Significance of Tumor Necrosis Factor Receptors in Human Myocardium

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Tumour necrosis factor-alpha uncouples respiration in isolated rat mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Inflammatory mediators and the failing heart: past, present, and the foreseeable future

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Delayed expression of cytokines after reperfused myocardial infarction: possible trigger for cardiac dysfunction and ventricular remodeling

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Improved myocardial ischemia/reperfusion injury in mice lacking tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

TNF-alpha antibodies are as effective as ischemic preconditioning in reducing infarct size in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Anti–Tumor Necrosis Factor-Alpha Improves Myocardial Recovery After Ischemia and Reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Tumor necrosis factor-alpha confers resistance to hypoxic injury in the adult mammalian cardiac myocyte

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

The role of TNF-alpha receptors p55 and p75 in acute myocardial ischemia/reperfusion injury and late preconditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Tumor necrosis factor-alpha is toxic via receptor 1 and protective via receptor 2 in a murine model of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

TNFalpha in myocardial ischemia/reperfusion: damage vs. protection

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Tumor necrosis factor-alpha and its receptors 1 and 2: Yin and Yang in myocardial infarction?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Plasma cytokine parameters and mortality in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Free radicals trigger TNF alpha-induced cardioprotection

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

TNFalpha-induced cytoprotection requires the production of free radicals within mitochondria in C2C12 myotubes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Tumor necrosis factor-induced protection of the murine heart is independent of p38-MAPK activation.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

The role of ADAM protease in the tyrosine kinase-mediated trigger mechanism of ischemic preconditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Role of tumor necrosis factor alpha and its receptor I in preconditioning by hyperoxia

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

The involvement of cytokines in the second window of ischaemic preconditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

The mitochondrial permeability transition pore and the Ca2+-activated K+ channel contribute to the cardioprotection conferred by tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Preconditioning the Myocardium: From Cellular Physiology to Clinical Cardiology

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

The myocardial JAK/STAT pathway: from protection to failure

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

The Jak-STAT pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

The Type I Angiotensin II Receptor Couples to Stat1 and Stat3 Activation Through Jak2 Kinase in Neonatal Rat Cardiac Myocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Activation of signal transducer and activator of transcription 3 protects cardiomyocytes from hypoxia/reoxygenation-induced oxidative stress through the upregulation of manganese superoxide dismutase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

An essential role of the JAK-STAT pathway in ischemic preconditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Role of STAT3 in ischemic preconditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Genetic depletion of cardiac myocyte STAT-3 abolishes classical preconditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Cardiotrophin-1 can protect cardiac myocytes from injury when added both prior to simulated ischaemia and at reoxygenation

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Erythropoietin protects the infant heart against ischemia-reperfusion injury by triggering multiple signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Erythropoietin affords additional cardioprotection to preconditioned hearts by enhanced phosphorylation of glycogen synthase kinase-3 beta

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

The JAK/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3 beta

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Diabetes abolishes morphine-induced cardioprotection via multiple pathways upstream of glycogen synthase kinase-3beta

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Signal transducer and activator of transcription 3 is involved in the cardioprotective signalling pathway activated by insulin therapy at reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

STAT-3 overexpression and p21 up-regulation accompany impaired regeneration of fatty livers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Regulation of Mcl-1 expression in rheumatoid arthritis synovial macrophages.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Atiprimod blocks STAT3 phosphorylation and induces apoptosis in multiple myeloma cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Cardiotrophin-1 is an essential factor in the natural defense of the liver against apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Connexin 43 in ischemic pre- and postconditioning.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

The complex of ciliary neurotrophic factor-ciliary neurotrophic factor receptor alpha up-regulates connexin43 and intercellular coupling in astrocytes via the Janus tyrosine kinase/signal transducer and activator of transcription pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Ischemic preconditioning activates phosphatidylinositol-3-kinase upstream of protein kinase C

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Localizing extracellular signal-regulated kinase (ERK) in pharmacological preconditioning's trigger pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Inconsistent relation of MAPK activation to infarct size reduction by ischemic preconditioning in pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Cross-talk between the survival kinases during early reperfusion: its contribution to ischemic preconditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Ischemic preconditioning protects by activating prosurvival kinases at reperfusion

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Myocardial protection by insulin at reperfusion requires early administration and is mediated via Akt and p70s6 kinase cell-survival signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

STAT3 as an adapter to couple phosphatidylinositol 3-kinase to the IFNAR1 chain of the type I interferon receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Carbon monoxide differentially modulates STAT1 and STAT3 and inhibits apoptosis via a phosphatidylinositol 3-kinase/Akt and p38 kinase-dependent STAT3 pathway during anoxia-reoxygenation injury

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

TEL-JAK2 mediates constitutive activation of the phosphatidylinositol 3'-kinase/protein kinase B signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

The PGE2-Stat3 interaction in doxorubicin-induced myocardial apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Prostaglandin E2 activates Stat3 in neonatal rat ventricular cardiomyocytes: A role in cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Distinctive role of Stat3 and Erk-1/2 activation in mediating interferon-gamma inhibition of TGF-beta1 action

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Production of growth related oncogene protein-alpha in human umbilical vein endothelial cells stimulated with soluble interleukin-6 receptor-alpha: role of signal transducers, janus kinase 2 and mitogen-activated kinase kinase

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

STAT3 attenuates EGFR-mediated ERK activation and cell survival during oxidant stress in mouse proximal tubular cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Signaling pathways in ischemic preconditioning

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Sphingosine kinase activation mediates ischemic preconditioning in murine heart

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

TNF-alpha, rheumatoid arthritis, and heart failure: a rheumatological dilemma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Drug insight: anti-tumor-necrosis-factor therapy for ankylosing spondylitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Protection from obesity-induced insulin resistance in mice lacking TNF-α function

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine-1-phosphate

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Peripartum cardiomyopathy: recent insights in its pathophysiology

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Serum tumour necrosis factor-alpha, interleukin-2 and interleukin-10 activation in stable angina and acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Tumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Tumor necrosis factor-alpha and mortality in heart failure: a community study

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Time course and prognostic significance of hemostatic changes in sepsis: relation to tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia and reperfusion.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YJMCC.2009.03.019

7 January 2021

Identifiers

10.1016/J.YJMCC.2009.03.019

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34974091&oldid=1370944606"